Pharmaceutical Access

image alt text
Photo: Justin Veneman, St. Jude Children’s Research Hospital; Memphis, Tenn.

Latest Update

Congress is currently reviewing two drug packages:
  • H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act
  • S. 2164: Lower Costs, More Cures Act of 2021

COVID-19 Update: our resource hub for children's hospitals tracks policy-related resources helpful to your work during the COVID-19 crisis.


COVID-19: Policy Resources for Children's Hospitals
January 6, 2022

This resource hub is designed to help you track policy-related resources helpful to your work during the COVID-19 crisis.

Analysis or Summary
CHA joins amicus brief to stop surprise billing arbitration provisions
December 16, 2021

We joined an amicus brief to stop surprise billing arbitration provisions.

Letter or Testimony
FDA Hospital and Health System Compounding Guidance Draft Comments
November 19, 2021

The FDA released revised guidance for industry.

Fact Sheet
340B Helps Kids
August 6, 2021

This resource provides information and statistics on the 340B program.

Angels for Change: Organization Takes on Drug Shortages to Provide Equal Access for Patients
June 23, 2021

A mom goes the distance for her daughter and hopes to transform the pharmaceutical supply chain.

Improving Patient Outcomes with a Pediatric Pharmacy
June 15, 2021

Yale New Haven Children's Hospital leveraged data and technology to improve the quality of care.

Talking Points
The 340B Program Helps Children's Hospitals Provide Essential Services to Kids
May 1, 2021

The 340B program supports children's hospitals in their mission to serve low-income, uninsured and under-insured patients.

Press Release
Hospital Groups Seek Action on Drug Company Violations of 340B Law
April 20, 2021

CHA and other six organizations representing hospitals and pharmacists urge HHS Secretary Becerra to halt the actions of six drug companies denying 340B discounts on prescription drugs.

Analysis or Summary
Congressional Relief Legislation and Children's Hospitals Requests in Response to COVID-19
April 1, 2021

Multiple packages for COVID-19 relief have passed to date. Read more about them here.

Press Release
Hospitals and Pharmacists File Lawsuit Over Drug Companies' Refusals of 340B Discounts
December 11, 2020

CHA and other hospital organizations filed a federal lawsuit today against HHS over the department's failure to enforce 340 Drug Discount Program requirements and halt drug company actions that undermine the program.

Analysis or Summary
CY 2021 Medicare OPPS Final Rule Summary
December 8, 2020

CMS released the CY 2021 Medicare OPPS final rule.

Letter or Testimony
Republican lawmakers request 340B stakeholder feedback
October 23, 2020

Republican lawmakers called on stakeholders to submit improvement ideas for the 340B program.

Analysis or Summary
Implications for Children of ACA Constitutionality Case
October 22, 2020

The Fifth Circuit Court of Appeals ruled that the ACA's individual mandate and the entire law is unconstitutional.

Fact Sheet
The Effects of Drug Shortages on Children's Hospitals and Their Patients
September 24, 2020

How children's hospitals are facing drug shortages.

Analysis or Summary
FY 2021 Medicare IPPS Final Rule Summary
September 17, 2020

CMS' released the FY 2021 Medicare Hospital Inpatient Prospective Payment System (IPPS) final rule.

Analysis or Summary
Section 1557 Final Rule Summary Highlights Roll Back of Nondiscrimination Protections; Impact of Recent Court Actions
August 28, 2020

HHS released a final rule to roll back key aspects of a former rule that implemented the ACA's non-discrimination provisions, known as Section 1557.

Research Confirms Drug Shortages Disproportionately Affect Children’s Hospitals
May 4, 2020

A project conducted by Vizient and CHA informs strategies to limit shortages of essential drugs in children’s hospitals.

Letter or Testimony
Allied 340B Groups Urge Senate Finance Leaders to Protect 340B
April 14, 2020

The 340B Coalition sent a letter to Senate Finance leadership asking them to prevent any changes to the 340B Drug Discount Program.

Letter or Testimony
CHA Submits Comments to OMB on Proposed 340B Hospital Survey
March 11, 2020

We submitted a comment letter on CMS' proposed hospital survey on 340B drug acquisition costs.

Analysis or Summary
Summary of Recent 340B Regulatory Developments
February 13, 2020

CHA developed a summary of federal regulatory activities related to the 340B program.

Analysis or Summary
MedPAC Examines 340B Drug Discount Program
January 23, 2020

On Jan. 17, 2020, MedPAC discussed whether the 340B program creates incentives for participating hospitals to use more expensive drugs.

Analysis or Summary
2019 State Child Health Policy Trends
January 10, 2020

This CHA report provides an analysis of state child health policy trends identified through calls with GRs and state children's hospital associations.

Analysis or Summary
CY 2020 Medicare OPPS Final Rule
December 31, 2019

CMS released the CY 2020 Medicare Hospital Outpatient Prospective Payment System final rule.

Analysis or Summary
Cures 2.0: CHA Letter Responding to RFI
December 18, 2019

CHA submitted comments to the request for information on a Cures 2.0 package.

Analysis or Summary
CMS announces plan to collect 340B drug acquisition price information
December 2, 2019

CMS announced a proposed hospital survey for specified covered outpatient drugs.


Policy Update Calls

Members receive the latest updates and suggest ways to best influence policy issues that impact children's health and children's hospitals in a weekly conference call.